278 Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 26 | 7.4 | 3.53× | q < 0.0001 | |
| Homogeneous non-metal compounds | 6 | 5.7 | 1.05× | q = 0.87 | |
| Homogeneous metal compounds | 7 | 13.1 | 0.54× | q = 0.04 | |
| Organic oxygen compounds | 0 | 5.3 | 0 | q = 0.01 | |
| Organic 1,3-dipolar compounds | 3 | 0.0 | 135× | not tested | |
| Organic acids and derivatives | 17 | 4.1 | 4.13× | not tested | |
| Lipids and lipid-like molecules | 6 | 3.0 | 2.02× | not tested | |
| Organoheterocyclic compounds | 4 | 4.1 | 0.98× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 216 |
| DB01677 | FUM | Fumaric acid | 29 |
| DB03343 | TEO | Malate Like Intermediate | 27 |
| DB02637 | OAA | Oxaloacetate Ion | 23 |
| DB18267 | HEM | Ferroheme | 18 |
| DB07373 | ANB | Boldione | 9 |
| DB00139 | SIN | Succinic acid | 6 |
| DB03317 | HEC | Ferroheme C | 5 |
| DB02175 | MLA | Malonic acid | 4 |
| DB00131 | AMP | Adenosine phosphate | 2 |
| DB01536 | ASD | Androstenedione | 2 |
| DB03553 | GUA | Glutaric Acid | 2 |
| DB00128 | ASP | Aspartic acid | 1 |
| DB01971 | URO | trans-urocanic acid | 1 |
| DB03247 | FMN | Flavin mononucleotide | 1 |
| DB03708 | ADX | Adenosine 5'-phosphosulfate | 1 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 1 |
| DB04657 | — | Carboxin | 1 |
| DB04795 | — | Thenoyltrifluoroacetone | 1 |
| DB08689 | — | Ubiquinone Q1 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 226 |
| NAmetal | SODIUM ION | 58 |
| FUM | FUMARIC ACID | 27 |
| TEO | MALATE LIKE INTERMEDIATE | 27 |
| OAA | OXALOACETATE ION | 23 |
| Kmetal | POTASSIUM ION | 19 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 17 |
| CL | CHLORIDE ION | 12 |
| UNL | Unknown ligand | 12 |
| ANB | ANDROSTA-1,4-DIENE-3,17-DIONE | 10 |
| SIN | SUCCINIC ACID | 7 |
| CAmetal | CALCIUM ION | 6 |
| MLA | MALONIC ACID | 4 |
| SFD | (S)-10-((2S,3S,4R)-5-((S)-((S)-(((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL)METHOXY)(HYDROXY)PHOSPHORYLOXY)(HYDROXY)PHOSPHORYLOXY)-2,3,4-TRIHYDROXYPENTYL)-7,8-DIMETHYL-2,4-DIOXO-2,3,4,4A-TETRAHYDROBENZO[G]PTERIDINE-5(10H)-SULFONIC ACID | 4 |
| 3NP | 3-NITROPROPANOIC ACID | 3 |
| ADX | ADENOSINE-5'-PHOSPHOSULFATE | 2 |
| AMP | ADENOSINE MONOPHOSPHATE | 2 |
| ASD | 4-ANDROSTENE-3-17-DIONE | 2 |
| GUA | GLUTARIC ACID | 2 |
| HEC | HEME C | 2 |